Entrada Therapeutics, Inc. TRDA
5.06 USD +0.34 (+7.20%)
At closeNov 4, 2026, 4:27 PM EST
5.06 0.00 0.00%
After hours · Nov 4, 4:27 PM ET
4.61 Day range 5.13
4.11 52-week range 16.45
- YTD
- -50.78%
- 1 year
- -23.56%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 25.42M | 210.78M | 129.01M | 0 | 0 | |
| 25.42M | 210.78M | 129.01M | 0 | 0 | |
| -157.90M | 47.01M | -3.16M | -97.25M | -51.13M | |
| -143.75M | 65.63M | -6.68M | -94.62M | -51.16M | |
| -3.47 | 1.68 | -0.20 | -3.02 | -8.16 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 94.34M | 101.21M | 71.55M | 49.11M | 291.06M | |
| 377.38M | 526.32M | 469.19M | 252.06M | 305.83M | |
| 71.25M | 97.64M | 226.83M | 39.50M | 7.12M | |
| 50.93M | 59.21M | 68.23M | 25.94M | 0 | |
| 306.13M | 428.68M | 242.36M | 212.55M | 298.72M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -128.51M | -41.56M | 139.80M | -93.79M | -50.86M | |
| 116.81M | -27.80M | -138.40M | -148.65M | -4.58M | |
| 887.00K | 102.96M | 21.04M | 479.00K | 307.46M | |
| -1.04M | -3.16M | -5.61M | -2.89M | -4.58M | |
| -10.82M | 33.61M | 22.45M | -241.96M | 252.02M |